Protego Biopharma Inc

Protego Biopharma, Inc. operates as a biotech company. The Company focuses on the discovery and development of small molecule therapeutics that aim to reprogram protein folding for the treatment of myopathy, cardiomyopathy, stroke, renal, retinal, channelopathies, and degenerative diseases. Protego Biopharma serves customers in the United States.